Clinical trial
Cholic Acid for Hepatic Steatosis in Lipodystrophy
NCT00457639 · University of Texas Southwestern Medical Center, Other · Completed
Key facts
| NCT number | NCT00457639 |
|---|---|
| Title | Cholic Acid for Hepatic Steatosis in Lipodystrophy |
| Official title | Phase II Study of Cholic Acid for Hepatic Steatosis in Lipodystrophy Patients |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | FDA Office of Orphan Products Development U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatic Steatosis |
| Intervention type | Drug |
| Interventions | Cholic Acid |
| Enrollment | 18 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Apr 6, 2007 |
| Last update posted | Aug 6, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: